Flavonoids as promising molecules in the cancer therapy : An insight

© 2023 Published by Elsevier B.V..

Cancer continues to increase global morbidity and mortality rates. Despite substantial progress in the development of various chemically synthesized anti-cancer drugs, the poor prognosis of the disease still remains a big challenge. The most common drawback of conventional cancer therapies is the emergence of drug resistance eventually leading to the discontinuation of chemotherapy. Moreover, advanced target-specific therapies including immunotherapy and stem cell therapy are expensive enough and are unaffordable for most patients in poorer nations. Therefore, alternative and cheaper therapeutic strategies are needed to complement the current cancer treatment approaches. Phytochemicals are bioactive compounds produced naturally by plants and have great potential in human health and disease. These compounds possess antiproliferative, anti-oxidant, and immunomodulatory properties. Among the phytochemicals, flavonoids are very effective in treating a wide range of diseases from cardiovascular diseases and immunological disorders to cancer. They scavenge reactive oxygen species (ROS), inhibit cancer metastasis, modulate the immune system and induce apoptotic or autophagic cell death in cancers. This review will discuss the potential of various phytochemicals particularly flavonoids in attempts to target various cancers.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

2023

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:6

Enthalten in:

Current research in pharmacology and drug discovery - 6(2023) vom: 30., Seite 100167

Sprache:

Englisch

Beteiligte Personen:

Mir, Suhail Ahmad [VerfasserIn]
Dar, Ashraf [VerfasserIn]
Hamid, Laraibah [VerfasserIn]
Nisar, Nasir [VerfasserIn]
Malik, Jonaid Ahmad [VerfasserIn]
Ali, Tabasum [VerfasserIn]
Bader, Ghulam Nabi [VerfasserIn]

Links:

Volltext

Themen:

Apoptosis
Autophagy
Flavonoids
Journal Article
Metastasis
Oxidative stress
Phytochemicals
Review

Anmerkungen:

Date Revised 25.12.2023

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.crphar.2023.100167

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366355473